Assertio Holdings (ASRT) Tezkor likvidlik koeffitsiyenti
Assertio Holdings, Inc. (ASRT) FDA tomonidan tasdiqlangan dori vositalarini sotib olish va ortiqcha xodimlarni chetlatish orqali xarajatlarni optimallashtirish yo'li bilan o'z biznesini kengaytirmoqda. Daromadlilik patent muddatining tugash sanalariga va yangi kelishuvlarning muvaffaqiyatiga bog'liq bo'lib, joriy ko'rsatkich 1.58 ni tashkil etadi. Faqat AQShda faoliyat yuritgani sababli tashqi savdo risklarining yo'qligi, ushbu narxlar grafigida aks etganidek, mazkur sog'liqni saqlash giganti aktivlari uchun bozor tendentsiyasini ta'kidlaydi.
%20Tezkor%20likvidlik%20koeffitsiyenti&width=1200&height=400&colorIndex=0&v=mvt4kixj.9g-7avve2o&start=20220704&end=20261029&filename=GURU_Markets_-_ASRT_-_Assertio-Holdings-Inc._-_Quick-Ratio "ASRT Assertio Holdings Tezkor likvidlik (04.07.2022 - 27.06.2026) | 👁️GURU.Markets👁️")
Assertio Holdings, Inc. kompaniyasining tahliliy kesimlari
- bozor qiymati va tahlilchilarning maqsadli prognozi:
- bozor kapitallashuvi tafsilotlari:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning kapitalga nisbati Assertio Holdings, Inc.|ASRT - Uzoq muddatli majburiyatlarning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati assertiotx.com|ASRT - Jamlangan qarz majburiyatlari|Qarzning balans qiymatiga nisbati Assertio Therapeutics|ASRT - Uzoq muddatli majburiyatlar miqdori|Kompaniyaning qisqa muddatli qarzlari Assertio|Tezkor likvidlik assertiotx.com
- foyda va bozor multiplikatorlari tafsilotlari:
Kompaniyaning jamlanma tahliliyoti:Assertio Holdings, ASRT
Tezkor koeffitsient Assertio Holdings, Inc. kompaniyasining naqd pul va debitorlik qarzlari hisobiga qisqa muddatli qarzlarni zudlik bilan to'lash qobiliyatini o'lchaydi va hisob-kitobdan illikvid zaxiralarni butunlay chiqarib tashlaydi. Tezkor likvidlik darajasini tahlil qilish orqali investor Assertio Holdings, Inc. kompaniyasining real to'lov qobiliyatini baholaydi, bu esa nevrologik dori vositalariga bo'lgan noelastik talab sharoitida sotib olingan brendlarni kengaytirishda hal qiluvchi ahamiyatga ega.
Assertio Holdings, Inc. raqobatchilari tahlili
Biogen Corp (BIIB) - Tezkor likvidlik|Shoshilinch likvidlik Neurocrine Corp (NBIX)|RGC (Regencell Bioscience) - Tezkor likvidlik koeffitsiyenti|Tezkor likvidlik koeffitsiyenti axsome.com|Tezkor likvidlik ACADIA Pharmaceuticals Inc. (ACAD)|Oraliq qoplama koeffitsiyenti Xenon Pharmaceuticals Inc.|Tezkor likvidlik Viking Pharma VKTX|Oraliq qoplama koeffitsiyenti Supernus Corp (SUPN)|Catalyst Pharmaceuticals - Tezkor likvidlik koeffitsiyenti|Shoshilinch likvidlik denalitherapeutics.com|Harmony Biosciences Holdings, Inc. (HRMY) - Tezkor likvidlik|Biohaven Ltd - Oraliq qoplash koeffitsiyenti|Tezkor likvidlik ko‘rsatkichi AMLX|TRVI (Trevi Corp) - Oraliq likvidlik koeffitsiyenti|Tezkor likvidlik koeffitsiyenti PRAX|Oraliq qoplama koeffitsiyenti anavex.com|Tezkor likvidlik CeriBell CBLL|Prothena Corp (PRTA) - Shoshilinch likvidlik|ALEC: Tezkor likvidlik ko‘rsatkichi|Oraliq qoplash koeffitsiyenti ANNX (Annexon Biosciences Inc.)|OMER: Tezkor likvidlik koeffitsiyenti|neurogene.com - Oraliq qoplash koeffitsiyenti|Tezkor likvidlik AC Immune SA|Shoshilinch likvidlik Voyager Therapeutics Inc VYGR|Tezkor likvidlik Neumora Therapeutics Inc (NMRA)|Tezkor likvidlik SCLX (Scilex Holding Company, Inc.)|Tezkor likvidlik koeffitsiyenti TVGN (Tevogen Bio Holdings)|ACOG: Shoshilinch likvidlik koeffitsiyenti|Cognition Therapeutics - Tezkor likvidlik koeffitsiyenti|Oraliq qoplama koeffitsiyenti Inhibikase Therapeutics Inc IKT|Cassava (SAVA) - Tezkor likvidlik|Shoshilinch likvidlik koeffitsiyenti COYA|VTGN (VistaGen Therapeutics, Inc.) - Tezkor likvidlik koeffitsiyenti|OVID - Kritik likvidlik|Tezkor likvidlik Acumen Pharmaceuticals, Inc. (ABOS)|Oraliq qoplama koeffitsiyenti CervoMed, Inc.|Alterity Therapeutics Limited - Tezkor likvidlik ko‘rsatkichi|Oraliq qoplash koeffitsiyenti CLNN|PepGen Corp - Tezkor likvidlik koeffitsiyenti|Oraliq qoplama koeffitsiyenti Jupiter Neurosciences, Inc. JUNS|Relmada Therapeutics, Inc. (RLMD) - Tezkor likvidlik|Shoshilinch likvidlik koeffitsiyenti ANVS|GRCE (Grace Therapeutics Inc) - Tezkor likvidlik koeffitsiyenti|Tezkor likvidlik ko‘rsatkichi Firefly Neuro (AIFF)|Tezkor likvidlik ko‘rsatkichi KLTO (Klotho Neurosciences Inc)|Oraliq qoplama koeffitsiyenti neurosense-tx.com|Tezkor likvidlik koeffitsiyenti RVPH (Reviva Pharmaceuticals Holdings, Inc.)|Tezkor likvidlik koeffitsiyenti MetaVia Inc. MTVA|NRXS - Tezkor likvidlik|Oraliq qoplama koeffitsiyenti Helius Medical HSDT|passagebio.com (PASG) - Tezkor likvidlik|Neuphoria Therapeutics - Oraliq qoplash koeffitsiyenti|Tezkor likvidlik ko‘rsatkichi NERV|ATHA (Athira Pharma Inc) - Oraliq likvidlik koeffitsiyenti|Tezkor likvidlik Addex Therapeutics, Ltd. (ADXN)|alzamend.com - Shoshilinch likvidlik koeffitsiyenti|Tezkor likvidlik koeffitsiyenti CYCN (Cyclerion Therapeutics, Inc.)|Protagenic Therapeutics Inc. (PTIX) - Shoshilinch likvidlik|KTTA: Tezkor likvidlik ko‘rsatkichi|CRGT - Tezkor likvidlik koeffitsiyenti|Avenue Therapeutics, Inc (ATXI) - Tezkor likvidlik|BrainStorm Cell Therapeutics Inc. - Oraliq qoplash koeffitsiyenti|Tezkor likvidlik Cara Therapeutics, Inc.|Shoshilinch likvidlik chromocell.com CHRO|Tezkor likvidlik koeffitsiyenti ELYM|Tezkor likvidlik koeffitsiyenti intracellulartherapies.com (ITCI)|Tezkor likvidlik Longboard Pharma LBPH|Oraliq qoplama koeffitsiyenti Marinus Pharma (MRNS)|NKGN - Tezkor likvidlik|Oraliq qoplama koeffitsiyenti neurobopharma.com NRBO|SAGE: Tezkor likvidlik koeffitsiyenti|Shoshilinch likvidlik Synaptogenix Inc. (SNPX)|Tezkor likvidlik Trevena, Inc|VIGL: Oraliq qoplash koeffitsiyenti|Tezkor likvidlik ko‘rsatkichi WENA (Anew Medical)|Oraliq likvidlik koeffitsiyenti CERE